We are live on ! Find out more
JP Morgan Chase

JP Morgan Chase Portfolio holdings

AUM $1.56T
1-Year Est. Return 27.86%
 

JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.

This Fund
S&P 500
This Quarter Est. Return
+8.22%
1 Year Est. Return
+27.86%
3 Year Est. Return
+90.49%
5 Year Est. Return
+115.47%
10 Year Est. Return
+468.9%
AUM
$920B
AUM Growth
+$99.4B
Cap. Flow
+$40.5B
Cap. Flow %
4.41%
Top 10 Hldgs %
19.57%
Holding
7,602
New
674
Increased
3,069
Reduced
2,328
Closed
737

Sector Composition

Rank Sector Weight
1 Technology 19.48%
2 Healthcare 10.48%
3 Financials 8.96%
4 Consumer Discretionary 8.42%
5 Industrials 7.07%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AUTL
5951
Autolus Therapeutics
AUTL
$389M
$4.28K ﹤0.01%
1,799
-439,226
-100% -$1.04M
FNWB icon
5952
First Northwest Bancorp
FNWB
$114M
$4.25K ﹤0.01%
373
OIA icon
5953
Invesco Municipal Income Opportunities Trust
OIA
$294M
$4.22K ﹤0.01%
676
+675
+67,500% +$4.2K
UP icon
5954
Wheels Up
UP
$203M
$4.2K ﹤0.01%
179
-439
-71% -$31K
CCCC icon
5955
C4 Therapeutics
CCCC
$389M
$4.13K ﹤0.01%
1,503
-32,360
-96% -$104K
NKTR icon
5956
Nektar Therapeutics
NKTR
$2.39B
$4.09K ﹤0.01%
475
-15,024
-97% -$160K
DGRE icon
5957
WisdomTree Trust WisdomTree Emerging Markets Quality Dividend Growth Fund
DGRE
$134M
$4.09K ﹤0.01%
180
-204
-53% -$4.59K
QAI icon
5958
NYLI Hedge Multi-Strategy Tracker ETF
QAI
$1B
$4.09K ﹤0.01%
137
-199
-59% -$5.85K
MNA icon
5959
IQ ARB Merger Arbitrage ETF
MNA
$251M
$4.07K ﹤0.01%
131
+98
+297% +$3.08K
SOAR.WS
5960
DELISTED
Volato Group, Inc. Redeemable Warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50
SOAR.WS
0
LNAI
5961
Lunai Bioworks
LNAI
$9.57M
$4.04K ﹤0.01%
89
-100
-53% -$7.67K
DMK
5962
DELISTED
DMK Pharmaceuticals Corporation Common Stock
DMK
$4.03K ﹤0.01%
1,684
+1,678
+27,967% +$7.17K
VTES icon
5963
Vanguard Short-Term Tax-Exempt Bond ETF
VTES
$2.08B
$4.02K ﹤0.01%
+40
New +$4.03K
GDV icon
5964
Gabelli Dividend & Income Trust
GDV
$2.59B
$4.01K ﹤0.01%
190
QLTA icon
5965
iShares AAA-A Rated Corporate Bond ETF
QLTA
$1.24B
$3.96K ﹤0.01%
84
-83
-50% -$3.93K
NMM icon
5966
Navios Maritime Partners
NMM
$2.22B
$3.93K ﹤0.01%
180
PBYI icon
5967
Puma Biotechnology
PBYI
$398M
$3.89K ﹤0.01%
1,103
FDIF icon
5968
Fidelity Disruptors ETF
FDIF
$98.1M
$3.89K ﹤0.01%
+156
New +$3.84K
LXP.PRC icon
5969
LXP Industrial Trust 6.5% Series C Preferred Stock
LXP.PRC
$3.87K ﹤0.01%
78
MUI
5970
DELISTED
BlackRock Municipal Income Fund, Inc.
MUI
$3.87K ﹤0.01%
338
-25,899
-99% -$296K
BBIG
5971
DELISTED
Vinco Ventures, Inc. Common Stock
BBIG
$3.82K ﹤0.01%
3,133
-5,890
-65% -$18.1K
BNZIW icon
5972
Banzai International Warrant
BNZIW
$144K
0
CBD
5973
DELISTED
Companhia Brasileira de Distribuicao
CBD
$3.8K ﹤0.01%
986
-548,683
-100% -$1.79M
RACY
5974
DELISTED
Relativity Acquisition Corp. Class A Common Stock
RACY
$3.79K ﹤0.01%
309
SPPI
5975
DELISTED
Spectrum Pharmaceuticals Inc
SPPI
$3.77K ﹤0.01%
3,924

Similar funds

JP Morgan Chase's Q2 2023 Portfolio in Review

As of Q2 2023, JP Morgan Chase held 7,602 positions worth $920B, up 12% from $821B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

JP Morgan Chase deployed $40.5B of net new capital in Q2 2023, opening 674 new positions and adding to 3,069 existing holdings. Its largest new stake was JPMorgan BetaBuilders Emerging Markets Equity ETF: 10,009,525 shares worth $488M.

By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 17% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was iShares 0-1 Year Treasury Bond ETF, an estimated $3.22B trimmed.

  • JP Morgan Chase's largest Q2 2023 buy was JPMorgan BetaBuilders Emerging Markets Equity ETF: 10,009,525 shares worth $488M.
  • JP Morgan Chase added most to Microsoft in Q2 2023, an estimated $5.77B increase.
  • JP Morgan Chase's biggest Q2 2023 reduction was iShares 0-1 Year Treasury Bond ETF, cutting an estimated $3.22B.
  • JP Morgan Chase fully exited DCP Midstream, LP in Q2 2023, selling an estimated $328M.
  • JP Morgan Chase's ten largest holdings make up 20% of its $920B portfolio in Q2 2023.
  • JP Morgan Chase opened 674 new positions and closed 737 in Q2 2023.
  • JP Morgan Chase's portfolio value rose 12% quarter-over-quarter to $920B.

Based on JP Morgan Chase's 13F filing for Q2 2023, filed 11 Aug 2023.